| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CCC.2005.01.005 |
| P698 | PubMed publication ID | 15781156 |
| P2093 | author name string | Mitchell P Fink | |
| Russell L Delude | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 177-196 | |
| P577 | publication date | 2005-04-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Critical Care Clinics | Q15757467 |
| P1476 | title | Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level | |
| P478 | volume | 21 |
| Q49375374 | A novel role for coinhibitory receptors/checkpoint proteins in the immunopathology of sepsis. |
| Q42963656 | A targeted extracorporeal therapy for endotoxemia: the time has come |
| Q35718469 | Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy: The Intraperitoneal Vacuum Randomized Controlled Trial. |
| Q38407334 | Acute kidney injury in severe sepsis: pathophysiology, diagnosis, and treatment recommendations |
| Q37754958 | Airway epithelial dysfunction in the development of acute lung injury and acute respiratory distress syndrome |
| Q90701330 | Altered expression of TIAM1 in endotoxin-challenged airway epithelial cells and rodent septic models |
| Q48013338 | Animal models of neuroinflammation secondary to acute insults originated outside the brain. |
| Q35681831 | Anticoagulants Influence the In Vitro Activity and Composition of Shock Lymph But Not Its In Vivo Activity |
| Q54267086 | Bile acids increase alveolar epithelial permeability via mitogen‐activated protein kinase, cytosolic phospholipase A2, cyclooxygenase‐2, prostaglandin E2 and junctional proteins |
| Q34014020 | Can we protect the gut in critical illness? The role of growth factors and other novel approaches |
| Q42112600 | Cardiorenal syndromes and sepsis |
| Q35621688 | Cecal ligation and puncture followed by methicillin-resistant Staphylococcus aureus pneumonia increases mortality in mice and blunts production of local and systemic cytokines |
| Q34743871 | Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis |
| Q55499573 | Closed Or Open after Source Control Laparotomy for Severe Complicated Intra-Abdominal Sepsis (the COOL trial): study protocol for a randomized controlled trial. |
| Q44545385 | Continuous Administration of Enteral Lipid- and Protein-Rich Nutrition Limits Inflammation in a Human Endotoxemia Model |
| Q35809342 | Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications |
| Q36972324 | Creating a Pro-survival and Anti-inflammatory Phenotype by Modulation of Acetylation in Models of Hemorrhagic and Septic Shock |
| Q35523910 | Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. |
| Q34033538 | Cytoskeletal regulation of epithelial barrier function during inflammation |
| Q50884238 | Detection of MAPK signal transduction proteins in an ischemia/reperfusion model of mouse intestine using in vivo cryotechnique |
| Q37605502 | Dexmedetomidine improves gastrointestinal motility after laparoscopic resection of colorectal cancer: A randomized clinical trial |
| Q36145271 | Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction |
| Q35947275 | Effect of Negative Pressure Therapy on the Inflammatory Response of the Intestinal Microenvironment in a Porcine Septic Model |
| Q56553170 | Effect of early fluid resuscitation combined with low dose cyclophosphamide on intestinal barrier function in severe sepsis rats |
| Q36254795 | Effects of glutamine on markers of intestinal inflammatory response and mucosal permeability in abdominal surgery patients: A meta-analysis |
| Q36871151 | Efficacy and safety of active negative pressure peritoneal therapy for reducing the systemic inflammatory response after damage control laparotomy (the Intra-peritoneal Vacuum Trial): study protocol for a randomized controlled trial |
| Q35045716 | Electroacupuncture activates enteric glial cells and protects the gut barrier in hemorrhaged rats |
| Q36089132 | Electroacupuncture at Zusanli Prevents Severe Scalds-Induced Gut Ischemia and Paralysis by Activating the Cholinergic Pathway |
| Q37203535 | Electroacupuncture improves gut barrier dysfunction in prolonged hemorrhagic shock rats through vagus anti-inflammatory mechanism |
| Q37279926 | Epidermal wound healing in severe sepsis and septic shock in humans |
| Q37673307 | Exogenous cytochrome C restores myocardial cytochrome oxidase activity into the late phase of sepsis |
| Q35725701 | Exploring the physiology and pathology of aging in the intestine of Drosophila melanogaster |
| Q37391830 | Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation |
| Q91791125 | Fibroblast growth factor 10 protects against particulate matter-induced airway inflammatory response through regulating inflammatory signaling and apoptosis |
| Q35025946 | Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target |
| Q35489494 | Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia |
| Q42533172 | HB-EGF protects the lungs after intestinal ischemia/reperfusion injury. |
| Q34212051 | HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury |
| Q27009994 | Have we enough glutamine and how does it work? A clinician's view |
| Q38380575 | Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects |
| Q36614045 | Heparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis |
| Q35652676 | High serum nitric oxide levels in patients with severe leptospirosis |
| Q35071467 | Human Leukocyte Antigen Class II Transgenic Mouse Model Unmasks the Significant Extrahepatic Pathology in Toxic Shock Syndrome |
| Q33816347 | Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model |
| Q49202522 | Human small intestine is capable of restoring barrier function after short ischemic periods |
| Q49387768 | Hypoxia preconditioning protects Ca2+-ATPase activation of intestinal mucosal cells against R/I injury in a rat liver transplantation model |
| Q34979942 | Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury |
| Q38194032 | Increased circulatory asymmetric dimethylarginine and multiple organ failure: bile duct ligation in rat as a model |
| Q88626354 | Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24 |
| Q42764517 | Inflammatory Mechanisms of Organ Crosstalk during Ischemic Acute Kidney Injury |
| Q40958947 | Inhibition of histone deacetylase 6 restores intestinal tight junction in hemorrhagic shock |
| Q37586391 | Inhibitory effects of serum from sepsis patients on epithelial cell migration in vitro: a case control study |
| Q53162542 | Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model |
| Q24656115 | Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition |
| Q36504406 | Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. |
| Q36157201 | Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness |
| Q35216279 | Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis |
| Q35071512 | Intestinal fatty acid binding protein as a marker for intra-abdominal pressure-related complications in patients admitted to the intensive care unit; study protocol for a prospective cohort study (I-Fabulous study). |
| Q36742141 | Introduction of an agent-based multi-scale modular architecture for dynamic knowledge representation of acute inflammation |
| Q91936388 | Is I-FABP not only a marker for the detection abdominal injury but also of hemorrhagic shock in severely injured trauma patients? |
| Q44979465 | Larazotide acetate promotes tight junction assembly in epithelial cells |
| Q37665071 | Low doses of celecoxib attenuate gut barrier failure during experimental peritonitis. |
| Q36906030 | Macrophage stimulating protein may promote tubular regeneration after acute injury |
| Q33640559 | Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference |
| Q38525452 | Microcirculatory and mitochondrial hypoxia in sepsis, shock, and resuscitation |
| Q34635234 | Modulation of Acetylation: Creating a Pro‐survival and Anti‐Inflammatory Phenotype in Lethal Hemorrhagic and Septic Shock |
| Q36931392 | Modulation of acute and chronic inflammation of the lung by GITR and its ligand. |
| Q33393642 | New Insight in Loss of Gut Barrier during Major Non-Abdominal Surgery |
| Q37821275 | Non-invasive assessment of barrier integrity and function of the human gut. |
| Q42364879 | Non-invasive markers of gut wall integrity in health and disease |
| Q42944740 | Nutritional stimulation of the autonomic nervous system |
| Q43794530 | Organ dysfunction during sepsis |
| Q27348706 | Periodic Exposure of Keratinocytes to Cold Physical Plasma: An In Vitro Model for Redox-Related Diseases of the Skin. |
| Q84995398 | Peritoneal Negative Pressure Therapy Prevents Multiple Organ Injury in a Chronic Porcine Sepsis and Ischemia/Reperfusion Model |
| Q44580788 | Physiopathology of acute renal failure during sepsis |
| Q36149184 | Polyethylene glycol versus dual sugar assay for gastrointestinal permeability analysis: is it time to choose? |
| Q36929093 | Prediction of Gut Wall Integrity Loss in Viral Gastroenteritis by Non-Invasive Marker |
| Q36633838 | Prognostic impact of fecal pH in critically ill patients. |
| Q42877924 | Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD. |
| Q33873370 | Protective effect of resin adsorption on septic plasma-induced tubular injury. |
| Q39777686 | Protective effect of the traditional Chinese medicine xuesaitong on intestinal ischemia-reperfusion injury in rats |
| Q60222274 | Quantitative Measure of Intestinal Permeability Using Blue Food Coloring |
| Q37279857 | Rapid development of intestinal cell damage following severe trauma: a prospective observational cohort study. |
| Q42487728 | Rapid lamina propria retraction and zipper‐like constriction of the epithelium preserves the epithelial lining in human small intestine exposed to ischaemia–reperfusion |
| Q31070494 | Real-Time In Vivo Imaging of Early Mucosal Changes during Ischemia-Reperfusion in Human Jejunum |
| Q27021300 | Redefining the gut as the motor of critical illness |
| Q34360664 | Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA |
| Q37438622 | Remodeling of the tight junction during recovery from exposure to hydrogen peroxide in kidney epithelial cells |
| Q37656182 | Removal of inflammatory ascites is associated with dynamic modification of local and systemic inflammation along with prevention of acute lung injury: in vivo and in silico studies |
| Q43358546 | Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress |
| Q42919046 | Role of TNF-alpha in lung tight junction alteration in mouse model of acute lung inflammation |
| Q43369504 | Role of peroxisome proliferator-activated receptor-alpha in ileum tight junction alteration in mouse model of restraint stress |
| Q35500956 | Sepsis: Something old, something new, and a systems view |
| Q36757452 | Sepsis: from pattern to mechanism and back. |
| Q43414745 | Serum albumin level during intestinal exfoliative rejection: a potential predictor of graft recovery and patient outcome |
| Q49471497 | Severe Abdominal Complaints after Technical Successful Endovascular Treatment of Chronic Splanchnic Ischemia |
| Q33733216 | Severe traumatic hemorrhagic shock induces compromised immune barrier function of the mesenteric lymph node leading to an increase in intestinal bacterial translocation |
| Q34798883 | Surgical sepsis and organ crosstalk: the role of the kidney |
| Q30248605 | The intestinal microbiome and surgical disease. |
| Q38213464 | The renal microcirculation in sepsis |
| Q43042235 | The study of n-3PUFAs protecting the intestinal barrier in rat HS/R model |
| Q38227863 | Tight junction physiology of pleural mesothelium |
| Q50162449 | Tight junction proteins in gallbladder epithelium: different expression in acute acalculous and calculous cholecystitis |
| Q92239205 | Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury |
| Q44774893 | Toward computational identification of multiscale "tipping points" in acute inflammation and multiple organ failure |
| Q35098770 | Translational systems approaches to the biology of inflammation and healing |
| Q53713252 | Trefoil factor 3 as a marker of intestinal cell damage during sepsis |
Search more.